Ze 339

· Max Zeller Soehne AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ze 339, covering 2012-01-26 to 2012-01-26. Get the full timeline:

Most recent: Clinical Trial Update: MOA Study of Ze 339 in Seasonal Allergic Rhinitis [Phase 2]